@article{fdi:010076211,
  title = {{E}conomic evaluations of onchocerciasis interventions : a systematic review and research needs},
  author = {{T}urner, {H}. {C}. and {W}alker, {M}. and {P}ion, {S}{\'e}bastien and {M}c{F}arland, {D}. {A}. and {B}undy, {D}. {A}. {P}. and {B}asanez, {M}. {G}.},
  editor = {},
  language = {{ENG}},
  abstract = {{O}bjective {T}o provide a systematic review of economic evaluations that has been conducted for onchocerciasis interventions, to summarise current key knowledge and to identify research gaps. {M}ethod {A} systematic review of the literature was conducted on the 8th of {A}ugust 2018 using the {P}ub{M}ed ({MEDLINE}) and {ISI} {W}eb of {S}cience electronic databases. {N}o date or language stipulations were applied to the searches. {R}esults {W}e identified 14 primary studies reporting the results of economic evaluations of onchocerciasis interventions, seven of which were cost-effectiveness analyses. {T}he studies identified used a variety of different approaches to estimate the costs of the investigated interventions/programmes. {O}riginally, the studies only quantified the benefits associated with preventing blindness. {G}radually, methods improved and also captured onchocerciasis-associated skin disease. {S}tudies found that eliminating onchocerciasis would generate billions in economic benefits. {T}he majority of the cost-effectiveness analyses evaluated annual mass drug administration ({MDA}). {T}he estimated cost per disability-adjusted life year ({DALY}) averted of annual {MDA} varies between {US}$3 and {US}$30 (cost year variable). {C}onclusions {T}he cost benefit and cost effectiveness of onchocerciasis interventions have consistently been found to be very favourable. {T}his finding provides strong evidential support for the ongoing efforts to eliminate onchocerciasis from endemic areas. {A}lthough these results are very promising, there are several important research gaps that need to be addressed as we move towards the 2020 milestones and beyond.},
  keywords = {onchocerciasis ; river blindness ; economic evaluations ; cost effectiveness ; cost-benefit analyses ; cost elimination ; health economics ; {AFRIQUE} {DE} {L}'{OUEST} ; {AFRIQUE} {SUBSAHARIENNE} ; {AMERIQUE} {LATINE}},
  booktitle = {},
  journal = {{T}ropical {M}edicine and {I}nternational {H}ealth},
  volume = {24},
  numero = {7},
  pages = {788--816},
  ISSN = {1360-2276},
  year = {2019},
  DOI = {10.1111/tmi.13241},
  URL = {https://www.documentation.ird.fr/hor/fdi:010076211},
}